Mandibulofacial Dysostosis with Microcephaly: Mutation and Database Update.

Autor: Huang L; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Vanstone MR; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Hartley T; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Osmond M; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Barrowman N; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada., Allanson J; Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.; Department of Genetics, The Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada., Baker L; Division of Medical Genetics, A. I. duPont Hospital for Children, Wilmington, Delaware., Dabir TA; Clinical Genetics Department, Belfast City Hospital, Belfast, UK., Dipple KM; Department of Pediatrics and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California., Dobyns WB; Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington.; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington., Estrella J; Department of Medical Genetics, Westmead Hospital, Sydney, Australia., Faghfoury H; The Fred A. Litwin Family Centre in Genetic Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Favaro FP; Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru, Brazil., Goel H; Hunter Genetics, Newcastle, Waratah, Australia.; University of Newcastle, Newcastle - School of Medicine and Public Health, Faculty of Health, Callaghan, Australia., Gregersen PA; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Gripp KW; Division of Medical Genetics, A. I. duPont Hospital for Children, Wilmington, Delaware., Grix A; Department of Genetics, Permanente Medical Group, Roseville, California., Guion-Almeida ML; Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru, Brazil., Harr MH; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; The Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania., Hudson C; Shodair Children's Hospital, Helena, Montana., Hunter AG; Medical Geneticist, Ottawa, Ontario, Canada., Johnson J; Shodair Children's Hospital, Helena, Montana.; Clinical Genetics and Metabolism, Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts., Joss SK; West of Scotland Clinical Genetics Service, South Glasgow University Hospital, Glasgow, UK., Kimball A; Harvey Institute for Human Genetics, Greater Baltimore Medical Center, Baltimore, Maryland., Kini U; Department of Clinical Genetics, Oxford University Hospitals NHS Trust, Oxford, UK., Kline AD; Harvey Institute for Human Genetics, Greater Baltimore Medical Center, Baltimore, Maryland., Lauzon J; Department of Medical Genetics, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada., Lildballe DL; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., López-González V; Sección de Genética Médica, Servicio de Pediatría, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain.; Grupo Clínico Vinculado al Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Martinezmoles J; Department of Genetics, Sacramento Medical Center, Sacramento, California., Meldrum C; NSW Health Pathology, Newcastle, Australia., Mirzaa GM; Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington.; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington., Morel CF; The Fred A. Litwin Family Centre in Genetic Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Morton JE; West Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, UK., Pyle LC; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Quintero-Rivera F; Department of Pathology and Laboratory Medicine, UCLA Clinical Genomics Center, David Geffen School of Medicine, University of California, Los Angeles, California., Richer J; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Department of Genetics, The Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada., Scheuerle AE; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas., Schönewolf-Greulich B; Genetic Counselling Clinic Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark., Shears DJ; Oxford Regional Genetics Service, The Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK., Silver J; The Fred A. Litwin Family Centre in Genetic Medicine, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Smith AC; Department of Genetics, The Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada., Temple IK; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.; Wessex Clinical Genetics Service, Princess Anne Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK., van de Kamp JM; Department of Clinical Genetics, VU Medical Center, Amsterdam, The Netherlands., van Dijk FS; Department of Clinical Genetics, VU Medical Center, Amsterdam, The Netherlands., Vandersteen AM; Maritime Medical Genetics Service, IWKHealth Centre, Halifax, Nova Scotia, Canada., White SM; Victoria Clinical Genetics Service, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Australia., Zackai EH; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Zou R; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Bulman DE; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Newborn Screening Ontario, The Children's Hospital of Eastern Ontario, Ottawa, Canada., Boycott KM; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Department of Genetics, The Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada., Lines MA; The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.; Metabolics and Newborn Screening, Department of Pediatrics, The Children's Hospital of Eastern Ontario, Ottawa, Canada.
Jazyk: angličtina
Zdroj: Human mutation [Hum Mutat] 2016 Feb; Vol. 37 (2), pp. 148-54. Date of Electronic Publication: 2015 Nov 19.
DOI: 10.1002/humu.22924
Abstrakt: Mandibulofacial dysostosis with microcephaly (MFDM) is a multiple malformation syndrome comprising microcephaly, craniofacial anomalies, hearing loss, dysmorphic features, and, in some cases, esophageal atresia. Haploinsufficiency of a spliceosomal GTPase, U5-116 kDa/EFTUD2, is responsible. Here, we review the molecular basis of MFDM in the 69 individuals described to date, and report mutations in 38 new individuals, bringing the total number of reported individuals to 107 individuals from 94 kindreds. Pathogenic EFTUD2 variants comprise 76 distinct mutations and seven microdeletions. Among point mutations, missense substitutions are infrequent (14 out of 76; 18%) relative to stop-gain (29 out of 76; 38%), and splicing (33 out of 76; 43%) mutations. Where known, mutation origin was de novo in 48 out of 64 individuals (75%), dominantly inherited in 12 out of 64 (19%), and due to proven germline mosaicism in four out of 64 (6%). Highly penetrant clinical features include, microcephaly, first and second arch craniofacial malformations, and hearing loss; esophageal atresia is present in an estimated ∼27%. Microcephaly is virtually universal in childhood, with some adults exhibiting late "catch-up" growth and normocephaly at maturity. Occasionally reported anomalies, include vestibular and ossicular malformations, reduced mouth opening, atrophy of cerebral white matter, structural brain malformations, and epibulbar dermoid. All reported EFTUD2 mutations can be found in the EFTUD2 mutation database (http://databases.lovd.nl/shared/genes/EFTUD2).
(© 2015 WILEY PERIODICALS, INC.)
Databáze: MEDLINE
Externí odkaz: